PDCD1 and autoimmune disease: Our studies highlight a path forward to generate more effective, potent PD-1 agonists that can inhibit T cell function, are biologically inactive in solution, and have scope to treat autoimmune diseases, an area of high unmet need, where effective and safe new therapies are urgently needed.